1. Home
  2. IDAI vs AIMD Comparison

IDAI vs AIMD Comparison

Compare IDAI & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo T Stamp Inc.

IDAI

T Stamp Inc.

HOLD

Current Price

$2.07

Market Cap

12.9M

Sector

Technology

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$1.55

Market Cap

13.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDAI
AIMD
Founded
2016
1984
Country
United States
United States
Employees
N/A
41
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9M
13.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
IDAI
AIMD
Price
$2.07
$1.55
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
46.3K
12.9K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
76.50
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$103.06
N/A
Revenue Next Year
$140.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.80
$0.44
52 Week High
$5.28
$4.50

Technical Indicators

Market Signals
Indicator
IDAI
AIMD
Relative Strength Index (RSI) 35.25 37.78
Support Level N/A $1.33
Resistance Level $2.76 $1.69
Average True Range (ATR) 0.17 0.09
MACD -0.04 -0.03
Stochastic Oscillator 0.00 8.62

Price Performance

Historical Comparison
IDAI
AIMD

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: